1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics

Tavares Gesiane; Venturini Gabriela; Padilha KallyandraZatz RobertoPereira Alexandre C.Thadhani Ravi I.Rhee Eugene P.Titan Silvia M. O.

首页> 外文期刊>Metabolomics : >1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics

【24h】

1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics

机译：1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Introduction Metabolomics allows exploration of novel biomarkers and provides insights on metabolic pathways associated with disease. To date, metabolomics studies on CKD have been largely limited to Caucasian populations and have mostly examined surrogate end points.

著录项

来源
《Metabolomics :》 |2018年第4期|Article:39-Article:39|共9页
作者
Tavares Gesiane; Venturini Gabriela; Padilha KallyandraZatz RobertoPereira Alexandre C.Thadhani Ravi I.Rhee Eugene P.Titan Silvia M. O.;
展开▼
作者单位

Univ Sao Paulo, Med Sch, Nephrol Div, Av Dr Eneas de Carvalho Aguiar 255, BR-05403000 Sao Paulo, SP;

Univ Sao Paulo, Med Sch, Heart Inst, Lab Genet & Mol Cardiol, Sao Paulo, SP, Brazil;

Massachusetts Gen Hosp, Dept Med, Div Nephrol, Boston, MA 02114 USA;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类生理学;
关键词
Diabetic kidney disease; Metabolomics; 1; 5-Anhydroglucitol;

1,5-Anhydroglucitol predicts CKD progression in macroalbuminuric diabetic kidney disease: results from non-targeted metabolomics

摘要

著录项

相关主题

期刊订阅